Literature DB >> 10775634

Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection.

C Rollier1, C Charollois, C Jamard, C Trepo, L Cova.   

Abstract

The outcome and protective efficacy of maternal antibodies elicited by DNA immunization to the large (L) hepadnavirus envelope protein were studied using the duck hepatitis B virus (DHBV) model. Following genetic immunization of breeding ducks with a DHBV L protein gene-bearing plasmid, specific and highly neutralizing antibodies were transferred from the sera of immunized ducks, via the egg yolk, to the progeny of vaccinees. Interestingly, large amounts (60 to 100 mg/egg) of high-titer and L protein-specific yolk immunoglobulins (immunoglobulin Y) accumulated in the egg yolk. These results suggest that eggs from genetically immunized avians may represent a potent source of DNA-designed antibodies specific to viral antigen. Importantly, these antibodies are vertically transmitted and protect offspring against high-titer DHBV challenge.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775634      PMCID: PMC112018          DOI: 10.1128/jvi.74.10.4908-4911.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

Review 1.  DNA vaccines.

Authors:  J Encke; J zu Putlitz; J R Wands
Journal:  Intervirology       Date:  1999       Impact factor: 1.763

Review 2.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; J W Shiver; M A Liu
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  The role of antibody concentration and avidity in antiviral protection.

Authors:  M F Bachmann; U Kalinke; A Althage; G Freer; C Burkhart; H Roost; M Aguet; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus.

Authors:  A M Prince; R Whalen; B Brotman
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

5.  Yolk-sac transmission and post-hatching ontogeny of serum immunoglobulins in the duck (Anas platyrhynchos).

Authors:  S S Liu; D A Higgins
Journal:  Comp Biochem Physiol B       Date:  1990

6.  Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.

Authors:  A R Jilbert; D S Miller; C A Scougall; H Turnbull; C J Burrell
Journal:  Virology       Date:  1996-12-15       Impact factor: 3.616

7.  DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

Authors:  H L Davis; M Mancini; M L Michel; R G Whalen
Journal:  Vaccine       Date:  1996-06       Impact factor: 3.641

8.  Chicken antibodies: a tool to avoid interference by complement activation in ELISA.

Authors:  A Larsson; P E Wejåker; P O Forsberg; T Lindahl
Journal:  J Immunol Methods       Date:  1992-11-25       Impact factor: 2.303

9.  Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning.

Authors:  S Chassot; V Lambert; A Kay; C Godinot; C Trepo; L Cova
Journal:  Virology       Date:  1994-04       Impact factor: 3.616

Review 10.  The structure of hepatitis B envelope and molecular variants of hepatitis B virus.

Authors:  C R Howard
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

View more
  6 in total

1.  DNA vaccine: a promising new approach for chronic hepatitis B therapy.

Authors:  Lucyna Cova
Journal:  Future Virol       Date:  2007-09       Impact factor: 1.831

2.  IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection.

Authors:  Jian-Er Long; Li-Na Huang; Zhi-Qiang Qin; Wen-Yi Wang; Di Qu
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

3.  Rapid production of neutralizing antibody leads to transient hepadnavirus infection.

Authors:  Yong-Yuan Zhang; Jesse Summers
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.

Authors:  A Thermet; M Robaczewska; C Rollier; O Hantz; C Trepo; G Deleage; L Cova
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).

Authors:  Rebecca Brocato; Matthew Josleyn; John Ballantyne; Pablo Vial; Jay W Hooper
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.

Authors:  Kai Dallmeier; Ursula Schultz; Michael Nassal
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.